The Cooper Companies CFO Gregory W. Matz to Retire; Albert G. White Named Successor in Planned Transition
02 September 2016 - 6:15AM
The Cooper Companies, Inc. (NYSE:COO) today announced that Gregory
W. Matz, senior vice president, chief financial officer and chief
risk officer, plans to retire from the company in early 2017 after
more than six years of service to the company. As part of his
planned transition, Mr. Matz intends to remain in his current role
through fiscal year end October 31, 2016, and then act in an
advisory capacity until March 2017 to ensure a smooth
transition. Albert G. White, III will succeed Mr. Matz as
chief financial officer, effective November 1, 2016. Mr.
White will assume this role in addition to his current
responsibilities as executive vice president and chief strategy
officer of Cooper Companies, which includes responsibility for
leading CooperSurgical.
“Greg has played a key role in helping Cooper deliver meaningful
returns to our shareholders. On behalf of our Company, I want to
thank him for his service and wish him the best in his retirement
and future endeavors,” said Robert S. Weiss, Cooper’s president and
chief executive officer.
Weiss added, “Al is a true professional with deep knowledge of
the Cooper business built since joining the Company in 2006. He has
excelled in key leadership positions at Cooper including leading
CooperSurgical, strategy, treasury, IR, and communications. He also
worked closely with Cooper in a banking capacity for many years
prior to joining the company. I am highly confident in Al’s
leadership and capabilities required for this expanded role.”
About The Cooper CompaniesThe Cooper Companies,
Inc. ("Cooper") is a global medical device company publicly traded
on the NYSE (NYSE:COO). Cooper is dedicated to being A Quality of
Life Company™ with a focus on delivering shareholder value. Cooper
operates through two business units, CooperVision and
CooperSurgical. CooperVision brings a refreshing perspective on
vision care with a commitment to developing a wide range of
high-quality products for contact lens wearers and providing
focused practitioner support. CooperSurgical is committed to
advancing the health of families with its diversified portfolio of
products and services focusing on women’s health, fertility and
diagnostics. Headquartered in Pleasanton, CA, Cooper has
approximately 10,000 employees with products sold in over 100
countries. For more information, please visit
www.coopercos.com.
COO-G
CONTACT:
Kim Duncan
Vice President, Investor Relations
The Cooper Companies, Inc.
ir@cooperco.com
Cooper Companies (NYSE:COO)
Historical Stock Chart
From Apr 2024 to May 2024
Cooper Companies (NYSE:COO)
Historical Stock Chart
From May 2023 to May 2024